1. Home
  2. GLAD vs CADL Comparison

GLAD vs CADL Comparison

Compare GLAD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Capital Corporation

GLAD

Gladstone Capital Corporation

N/A

Current Price

$18.40

Market Cap

430.6M

Sector

Finance

ML Signal

N/A

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$5.42

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLAD
CADL
Founded
2001
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.6M
455.8M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
GLAD
CADL
Price
$18.40
$5.42
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
★ $22.00
$17.67
AVG Volume (30 Days)
138.6K
★ 1.4M
Earning Date
11-17-2026
11-12-2026
Dividend Yield
★ 9.54%
N/A
EPS Growth
★ 91.82
58.62
EPS
★ 1.00
N/A
Revenue
N/A
★ $125,000.00
Revenue This Year
$12.97
N/A
Revenue Next Year
$9.43
N/A
P/E Ratio
$18.85
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.54
$4.35
52 Week High
$21.73
$14.00

Technical Indicators

Market Signals
Indicator
GLAD
CADL
Relative Strength Index (RSI) 37.50 27.63
Support Level $18.35 $4.62
Resistance Level $19.74 $5.51
Average True Range (ATR) 0.44 0.72
MACD -0.06 -0.30
Stochastic Oscillator 0.31 4.95

Price Performance

Historical Comparison
GLAD
CADL

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: